Cargando…
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients
(1) Background: Developing strategies to identify significant liver fibrosis in people with HIV (PWH) is crucial to prevent complications of non-alcoholic fatty liver disease (NAFLD). We aim to investigate if five simple serum biomarkers applied to PWH can optimize a care pathway to identify signifi...
Autores principales: | Sebastiani, Giada, Milic, Jovana, Cervo, Adriana, Saeed, Sahar, Krahn, Thomas, Kablawi, Dana, Al Hinai, Al Shaima, Lebouché, Bertrand, Wong, Philip, Deschenes, Marc, Gioè, Claudia, Cascio, Antonio, Mazzola, Giovanni, Guaraldi, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874585/ https://www.ncbi.nlm.nih.gov/pubmed/35207770 http://dx.doi.org/10.3390/jpm12020282 |
Ejemplares similares
-
A43 SEX DIFFERENCES IN THE ASSOCIATION OF HIV WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)
por: Kablawi, D, et al.
Publicado: (2023) -
The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study
por: Sebastiani, Giada, et al.
Publicado: (2022) -
Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
por: Benmassaoud, Amine, et al.
Publicado: (2018) -
A79 THE RELATIONSHIP BETWEEN VISCERAL ADIPOSITY AND NONALCOHOLIC FATTY LIVER DISEASE DIAGNOSED BY CONTROLLED ATTENUATION PARAMETER IN PEOPLE WITH HIV: A PILOT STUDY
por: Elgretli, W, et al.
Publicado: (2023) -
Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort
por: Cinque, Felice, et al.
Publicado: (2023)